Angelini Holding announced its consolidated financial statements for FY 2023, highlighting substantial growth compared to 2022.

Angelini Industries, the Italian industrial group with a global presence in 21 countries, reported revenues of 2,149.6 million euros, marking a 7% increase from the previous year.

The Health sector, led by Angelini Pharma and Angelini Ventures, was a significant contributor, accounting for 57% of total revenues.

Angelini Ventures, the international venture capital arm of the group, invested 52.9 million euros in 2023 in innovative BioTech, Medtech, and Digital Health solutions.

Discover the strategic growth, key investments, and future plans driving this success – click to read the full news and explore the details of Angelini Holding’s impressive annual report for 2023